The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?

A few decades ago, the therapy goal of patients with systemic lupus erythematosus (SLE) was survival and the prevention of organ failure. Today, clinical remission and low disease activity are believed to be the optimal therapeutic targets. These aims are difficult to reach for many patients, but th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kernder, Anna, Elefante, Elena, Chehab, Gamal, Tani, Chiara, Mosca, Marta, Schneider, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719037/
https://www.ncbi.nlm.nih.gov/pubmed/33280017
http://dx.doi.org/10.1093/rheumatology/keaa427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719037/
https://www.ncbi.nlm.nih.gov/pubmed/33280017
http://dx.doi.org/10.1093/rheumatology/keaa427

Ejemplares similares